YFM-32155-11322

2 vaccinations 12 coded responses 12 check-ins 12 free-text entries 6 call cases

Sex: Female
Age at first dose: 31-35
ZIP prefix: 201 / VA
Registered: 2021-06-04

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-05-14
Dose 1 — Pfizer-BioNTech
2021-06-04
Registered in v-safe
2021-06-04
Dose 2 — Pfizer-BioNTech
2021-06-04
Survey response — day 0, dose 2
MedDRA: Tachycardia — Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: tachycardia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-04
Report sent to call center — day 0, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-05
Survey response — days 1–6 daily, dose 2
MedDRA: Tachycardia — Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Tachycardia

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-06
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-07
Survey response — days 1–6 daily, dose 2
MedDRA: Burning sensation, Dizziness, Hypoaesthesia — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Dizziness, numbness, burning sensation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-08
Survey response — days 1–6 daily, dose 2
MedDRA: Burning sensation, Dizziness, Hypoaesthesia, Tachycardia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea

Free text: Dizziness, tachycardia, burning sensation, numbness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-09
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness, Urticaria — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activities

Free text: Hives, moderate dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-10
Survey response — days 1–6 daily, dose 2
MedDRA: Burning sensation, Dizziness, Hypoaesthesia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Moderate dizziness, burning sensations & numbness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-10
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-11
Survey response — day 7, dose 2
MedDRA: Burning sensation, Dizziness — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Dizziness, burning sensation

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-17
Call 2 — Left Voicemail
2021-06-18
Survey response — day 14, dose 2
MedDRA: Asthenia, Chills, Dizziness, Fatigue, Hypertension, Pain, Pyrexia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Fatigue, weakness, chills, high blood pressure, dizziness, fever, body aches

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-18
Report sent to call center — day 14, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-06-24
Call 2 — Left Voicemail
2021-06-27
Survey response — day 21, dose 2
MedDRA: Arthralgia, Chills, Dizziness, Fatigue, Myalgia, Presyncope — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Severe fatigue, muscle pain, joint pain, chills, dizziness, near syncope

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-27
Report sent to call center — day 21, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-30
Call 2 — Left Voicemail
2021-09-05
Survey response — 3 months, dose 2
MedDRA: Abdominal pain, Haemorrhagic ovarian cyst, Lymphadenopathy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit

Free text: Abdominal pain, possible ulcer, hemorrhagic ovarian cyst, enlarged lymph nodes

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-09-05
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-09-07
Call 2 — Left Voicemail
2022-06-07
Survey response — 12 months, dose 2
MedDRA: Anaemia, Nervous system disorder, Visual impairment — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Anemia, neurological issues, vision changes

MedDRA releases: 2024-11 · check-in free text available
2022-06-07
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-06-08
Call 1 — Left Voicemail
2022-06-08
Call 1 — Left Voicemail
2022-06-08
Call 1 — Left Voicemail
2022-06-08
Call 1 — Left Voicemail
2022-06-08
Call 1 — Left Voicemail
2022-06-08
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-05-14	Pfizer-BioNTech
2	2021-06-04	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-06-04	Unsuccessful
2021-06-10	Unsuccessful
2021-06-18	Unsuccessful
2021-06-27	Unsuccessful
2021-09-05	Unsuccessful
2022-06-07	Unsuccessful

Free text

Release 8 — day 0, dose 2

2021-06-04

Systemic reaction (other): tachycardia

Release 8 — days 1–6 daily, dose 2

2021-06-05

Systemic reaction (other): Tachycardia

2021-06-06

Systemic reaction (other): Dizziness

2021-06-07

Systemic reaction (other): Dizziness, numbness, burning sensation

2021-06-08

Systemic reaction (other): Dizziness, tachycardia, burning sensation, numbness

Release 9 — days 1–6 daily, dose 2

2021-06-09

Systemic reaction (other): Hives, moderate dizziness

2021-06-10

Systemic reaction (other): Moderate dizziness, burning sensations & numbness

Release 9 — day 7, dose 2

2021-06-11

Systemic reaction (other): Dizziness, burning sensation

Release 9 — day 14, dose 2

2021-06-18

Symptoms: Fatigue, weakness, chills, high blood pressure, dizziness, fever, body aches

Release 9 — day 21, dose 2

2021-06-27

Symptoms: Severe fatigue, muscle pain, joint pain, chills, dizziness, near syncope

Release 9 — 3 months, dose 2

2021-09-05

Symptoms: Abdominal pain, possible ulcer, hemorrhagic ovarian cyst, enlarged lymph nodes

Release 11 — 12 months, dose 2

2022-06-07

Symptoms: Anemia, neurological issues, vision changes

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abdominal pain	✓	·	✓
SD	Anaemia	·	·	✓
SD	Arthralgia	✓	✓	✓
SD	Asthenia	✓	✓	✓
SD	Chills	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Haemorrhagic ovarian cyst	✓	·	✓
SD	Hypertension	✓	✓	✓
SD	Lymphadenopathy	✓	·	✓
SD	Myalgia	✓	✓	✓
SD	Nervous system disorder	·	·	✓
SD	Pain	✓	✓	✓
SD	Presyncope	✓	✓	✓
SD	Pyrexia	✓	✓	✓
SD	Visual impairment	·	·	✓
SRO	Burning sensation	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Hypoaesthesia	✓	✓	✓
SRO	Tachycardia	✓	✓	✓
SRO	Urticaria	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release